Literature DB >> 24295190

Genetics' influence on patient experiences with a rare chronic disorder: a photovoice study of living with alpha-1 antitrypsin deficiency.

Pamela Holtzclaw Williams1, Lucinda Shore, Marvin Sineath, Jim Quill, Barbara Warner, Jamila Keith, Deirdre Walker, Sara Wienke, Susan Flavin, Charlie Strange.   

Abstract

Patients with rare chronic disorders and their caregivers increasingly form communities to support and exchange social experiences. Because up to 10% of the United States population is affected by one of 5000 to 6000 rare disorders, efforts to understand the individuals and affected communities are important. This study was conducted using community-based participatory research approaches within a community of patients and caregivers living with alpha-1 antitrypsin (AAT) deficiency. Patient populations at some risk for lung transplant include individuals who smoked cigarettes and patients who underwent liver transplant in infancy and later adulthood due to accumulation of misfolded AAT within hepatocytes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic diseases; Genetics; Photovoice

Mesh:

Year:  2013        PMID: 24295190      PMCID: PMC4437222          DOI: 10.1016/j.cnur.2013.09.008

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  21 in total

1.  Parental stress in families of children with a genetic disorder/disability and the resiliency model of family stress, adjustment, and adaptation.

Authors:  Heather R Hall; Susan L Neely-Barnes; J Carolyn Graff; Taylor E Krcek; Ruth J Roberts; Jane S Hankins
Journal:  Issues Compr Pediatr Nurs       Date:  2012

2.  Chronic obstructive pulmonary disease as disability: dilemma stories.

Authors:  Christina McMillan Boyles; Patricia Hill Bailey; Sharolyn Mossey
Journal:  Qual Health Res       Date:  2010-09-20

3.  Negotiating desires and options: how mothers who carry the fragile X gene experience reproductive decisions.

Authors:  Kelly Amanda Raspberry; Debra Skinner
Journal:  Soc Sci Med       Date:  2011-02-03       Impact factor: 4.634

4.  Understanding the experiences of youth living with sickle cell disease: a photovoice pilot.

Authors:  Jessica M Valenzuela; Lisa M Vaughn; Lori E Crosby; Heather Strong; Alexandra Kissling; Monica J Mitchell
Journal:  Fam Community Health       Date:  2013 Apr-Jun

Review 5.  Reproductive attitudes and behaviors in people with sickle cell disease or sickle cell trait: a qualitative interpretive meta-synthesis.

Authors:  Marcella Smith; Regina T P Aguirre
Journal:  Soc Work Health Care       Date:  2012

6.  The role of religious and existential well-being in families with Lynch syndrome: prevention, family communication, and psychosocial adjustment.

Authors:  Bronwyn A Morris; Donald W Hadley; Laura M Koehly
Journal:  J Genet Couns       Date:  2013-01-25       Impact factor: 2.537

7.  Examination of risk and resiliency in a pediatric sickle cell disease population using the psychosocial assessment tool 2.0.

Authors:  Cynthia W Karlson; Stacey Leist-Haynes; Maria Smith; Melissa A Faith; T David Elkin; Gail Megason
Journal:  J Pediatr Psychol       Date:  2012-07-26

8.  How disease advocacy organizations participate in clinical research: a survey of genetic organizations.

Authors:  David C Landy; Margaret A Brinich; Mary Ellen Colten; Elizabeth J Horn; Sharon F Terry; Richard R Sharp
Journal:  Genet Med       Date:  2012-02       Impact factor: 8.822

9.  The need for worldwide policy and action plans for rare diseases.

Authors:  John Forman; Domenica Taruscio; Virginia A Llera; Luis A Barrera; Timothy R Coté; Catarina Edfjäll; Désirée Gavhed; Marlene E Haffner; Yukiko Nishimura; Manuel Posada; Erik Tambuyzer; Stephen C Groft; Jan-Inge Henter
Journal:  Acta Paediatr       Date:  2012-05-11       Impact factor: 2.299

Review 10.  Genetic discrimination and life insurance: a systematic review of the evidence.

Authors:  Yann Joly; Ida Ngueng Feze; Jacques Simard
Journal:  BMC Med       Date:  2013-01-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.